Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04699773 · ClinicalTrials.gov registry record · NA
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
A NA study of Glioblastoma and Glioma, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 5
- Study locations
NCT04699773 is a NA study of Glioblastoma and Glioma that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 32 participants, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (71% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT04699773, a NA study of Glioblastoma and Glioma, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
Conditions Studied
Interventions
- RADIATION Hypofractionated Radiation Therapy
- PROCEDURE LITT
Study Locations (5)
Maryland
- Maryland Proton Treatment Center - Baltimore
- University of Maryland Greenebaum Cancer Center - Baltimore
- UCH Kaufman Cancer Center - Bel Air
- Central Maryland Radiation Oncology - Columbia
- Baltimore Washington Medical Center - Glen Burnie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-02-20 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04699773
The ClinicalTrials.gov registry entry for NCT04699773 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (71% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Glioblastoma appearing as the primary indexed condition, and to 2 interventions - of which Hypofractionated Radiation Therapy is the first listed.
NCT04699773 reports 5 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04699773 about?
NCT04699773 is a clinical study titled "LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)". The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
What is the current status of trial NCT04699773?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2021-02-20. Estimated completion is 2027-12.
What conditions does trial NCT04699773 study?
This clinical trial studies the following conditions: Glioblastoma, Glioma, Brain Tumor.
What interventions are being tested in trial NCT04699773?
The interventions under investigation include: Hypofractionated Radiation Therapy (RADIATION), LITT (PROCEDURE).
Who is sponsoring clinical trial NCT04699773?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04699773 being conducted?
This trial has 5 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
RECRUITING · NA
-
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
RECRUITING · NA
-
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.